Go Pro
LON:FDBK

Feedback (FDBK) Share Price, News & Analysis

Feedback logo
GBX 6.06 -0.04 (-0.66%)
As of 03:41 AM Eastern

About Feedback Stock (LON:FDBK)

Advanced

Key Stats

Today's Range
6.05
6.06
50-Day Range
6.06
9
52-Week Range
5.80
15
Volume
11,185 shs
Average Volume
130,863 shs
Market Capitalization
£2.66 million
P/E Ratio
N/A
Dividend Yield
4.56%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Feedback plc (AIM: FDBK) provides innovative software and systems through its trading subsidiary, Feedback Medical. Feedback liberates data and knowledge from multiple healthcare IT systems and delivers better workflows to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. It connects care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients. By linking different clinical systems together into a seamless view of the patient, Feedback can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers. Bleepa® is a communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance. CareLocker® is a patient-facing platform that gives patients access and control over their diagnostic and other clinical data. The Company has a number of growth opportunities domestically and internationally across a range of public and private healthcare markets including the NHS. Our highly scalable software-as-a-service (SaaS) based model is expected to provide increasing levels of revenue visibility as the Company grows its customer base.

Receive FDBK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Feedback and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

FDBK Stock News Headlines

Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to move out of overpriced AI stocks before the tech trade breaks down and into lesser-known names with real potential to challenge the Mag 7. One pick he calls 'an upgrade to Tesla stock' is a little-known company that just inked a partnership with Nvidia, positioning it ahead of Tesla in the autonomous vehicle race.tc pixel
Feedback plc Secures Shareholder Approval at AGM
See More Headlines

FDBK Stock Analysis - Frequently Asked Questions

Feedback's stock was trading at GBX 9.75 on January 1st, 2026. Since then, FDBK stock has decreased by 37.4% and is now trading at GBX 6.10.

Feedback plc (LON:FDBK) released its quarterly earnings results on Tuesday, February, 17th. The company reported ($3.98) EPS for the quarter. Feedback had a negative net margin of 845.25% and a negative trailing twelve-month return on equity of 135.17%.

Shares of Feedback reverse split on the morning of Friday, October 14th 2022.The 1-200 reverse split was announced on Friday, October 14th 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, October 14th 2022. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

Shares of FDBK stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Feedback investors own include 4D pharma (DDDD), Omega Diagnostics Group (ODX), Quadrise Fuels International (QFI), Advanced Oncotherapy (AVO), B&M European Value Retail (BME), Coats Group (COA) and genedrive (GDR).

Company Calendar

Last Earnings
2/17/2026
Today
8/02/2026

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Healthcare Technology
Sub-Industry
Healthcare Technology
Current Symbol
LON:FDBK
CIK
N/A
Fax
N/A
Employees
24
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (15.74)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£10.84 million
Net Margins
-845.25%
Pretax Margin
N/A
Return on Equity
-135.17%
Return on Assets
-22.99%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
10.34
Quick Ratio
18.41

Sales & Book Value

Annual Sales
£849.62 thousand
Price / Sales
3.15
Cash Flow
GBX 5.45 per share
Price / Cash Flow
1.12
Book Value
GBX 57.35 per share
Price / Book
0.11

Miscellaneous

Outstanding Shares
43,815,000
Free Float
N/A
Market Cap
£2.67 million
Optionable
Not Optionable
Beta
0.77
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (LON:FDBK) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners